Validation of a Nutrition Screening Tool

May 8, 2013 updated by: Royal Marsden NHS Foundation Trust

The Validation of Two Inpatient Adult Nutrition Screening Tools in Cancer Care - a Prospective Study

The objective of this study is to evaluate the sensitivity and specificity of two nutrition screening tools to identify inpatients with malnutrition or at risk of malnutrition. The two tools are the Royal Marsden Abridged Adult Nutrition Screening Tool (AANST) and the Malnutrition Screening Tool (MST)[10] The tools will be compared with the currently accepted gold standard, Patient Generated Subjective Global Assessment (PG-SGA). Both screening tools are in the form of scored questionnaires and are suitable for electronic input.

The ultimate objective is to select an adult inpatient nutrition screening tool with the highest sensitivity for future use in the oncology inpatient setting in order to allow prompt commencement of an appropriate nutrition care plan.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

128

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United Kingdom
    • London ..
      • London, London .., United Kingdom, SW3 6JJ
        • Royal Marsden Hospital NHS Foundation Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients will be approached for consideration and recruitment to the study in a stratified manner in order to proportionately represent the diagnostic groups admitted to The Royal Marsden NHS Foundation Trust as inpatients. Patients will be approached sequentially from the list until the required number of patients are recruited for that particular diagnoses. Recruitment for particular diagnostic groups may take place over a number of days until the required number of patients is recruited. The same procedure will be repeated, with a newly generated list, for all selected diagnostic groups in a random order. This methodology will aim to capture patients who have been newly diagnosed, patients with established disease, patients newly admitted and those who have been inpatients for anumber of days or weeks.

Description

Inclusion Criteria:

  • All adult inpatients, over the age of 18, admitted to RMH for whom a measured weight and height can be obtained

Exclusion Criteria

  • Patients for whom it is not possible to obtain a measured height and weight
  • People with a definitive diagnosis of dementia
  • People who lack capacity to understand the purpose of the study and to consent
  • Patients who are unable to understand and speak English

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sensitivity of Screening Tool
Time Frame: 24 hrs
The primary endpoint of the study is the sensitivity of each screening tool as compared to the gold standard of PG-SGA when completed by a trained dietitian.
24 hrs

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Specificity of the Tool
Time Frame: 24 hrs

Secondary endpoints are as follows:

  • specificity of the screening tool
  • proportion of inpatients with malnutrition on admission
24 hrs

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Royal Marsden NHS Foundation Trust

Investigators

  • Principal Investigator: Clare Shaw, Phd, Royal Marsden Hospital NHS Foundation Trust

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2011

Primary Completion (Actual)

September 1, 2012

Study Completion (Actual)

March 1, 2013

Study Registration Dates

First Submitted

April 20, 2012

First Submitted That Met QC Criteria

May 8, 2013

First Posted (Estimate)

May 13, 2013

Study Record Updates

Last Update Posted (Estimate)

May 13, 2013

Last Update Submitted That Met QC Criteria

May 8, 2013

Last Verified

May 1, 2013

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CCR 3621

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sarcoma

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe